BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Des Moines University - ECPv3.10//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:Des Moines University X-ORIGINAL-URL: X-WR-CALDESC:Events for Des Moines University BEGIN:VEVENT DTSTART:20130420T123000Z DTEND:20130420T213000Z DTSTAMP:20150704T033254Z CREATED:20130115T172956Z LAST-MODIFIED:20130115T172956Z SUMMARY:Improving Outcomes in Patients with Atrial Fibrillation: An Update for the Primary Care Provider DESCRIPTION:Register online A complete list of the patient/provider resources can be found here.Course directorsKevin Carnevale\, MDAcademic Pathologist - Microbiology and Immunology\,Des Moines UniversityCraig B. Clark\, DO\, FACC\, FAHA\, FASECardiologist\, Iowa Health Cardiology;Immediate Past-President\, Iowa Chapter of the American College of CardiologyTarget audiencePrimary care physicians\, internists\, hospitalists\, cardiologists\, neurologists\, anticoagulation and thrombosis specialists\, residents\, physician assistants\, nurses\, nurse practitioners\, cardiac techs\, support staff\, and all other interested health professionals.PurposeAtrial fibrillation (AFib) is the most common heart rhythm disorder seen by primary care physicians. AFib affects an estimated 2.7 million people in the United States and the incidence is expected to double within the next forty years. AFib negatively impacts patient’s quality of life and is a major risk factor for stroke. Despite practice guidelines for managing AFib\, it’s estimated that two-thirds of AFib-related strokes can be avoided. Gaps exist between the evidence base and clinical practice. Stroke in patients with AFib result in worse outcomes including higher mortality\, greater functional impairment and dependency. Although existing guidelines define effective therapeutic strategies for managing AFib to reduce stroke risk\, these strategies are frequently underused or inappropriately understood. Both provider and patient knowledge and attitudes play an important role in the success of current strategies to manage AFib to prevent stroke.ObjectivesUpon conclusion of this educational activity\, participants will be able to:Describe the incidence and consequences of untreated atrial fibrillation.Identify patients for whom antithrombotic management for atrial fibrillation or atrial flutter is appropriate.Document the risk of stroke using a validated assessment tool.Determine the relative risk and benefit of antithrombotic therapy for a given patient.Select the appropriate antithrombotic therapy including the role of newly approved antithrombotic agents.Determine which patients are best managed with a rate-control versus rhythm-control strategy.Discuss options for maintaining sinus rhythm including anti-arrhythmic drug therapy and the role of ablation.Recite emerging therapies for atrial fibrillation and prevention of its complications.AgendaDownload presentation objectives7:30 a.m.Registration and Breakfast8 a.m. Epidemiology\, Natural History and Risk Factors for Atrial FibrillationGary Hoff\, DO\, FACOI\, FACC\, Des Moines UniversityDr. Hoff indicated he has no financial relationships to disclose relevant to the content of this CME activity.8:20 a.m.Recent Insights into the Mechanisms of Atrial FibrillationSamuel J. Asirvatham\, MD\, Cardiology and Vascular Medicine\, Mayo Clinic\, MNDr. Asirvatham indicated he has received an honoraria for consulting with Abiomed\, Biotronik\, Boston Scientific\, Medtronic\, Spectranetics\, St. Jude\, Sanofi‐Aventis\, Stereotaxis\, Wolters Kluwer\, and Elsevier. He is also copatent holder and may receive future royalties from Nevro\, Aegis\, and ATP.8:50 a.m.Working Up the Patient with Newly Diagnosed Atrial FibrillationLisa Benton\, NP\, CCA\, State RepresentativeMs. Benton indicated she has no financial relationships to disclose relevant to the content of this CME activity.9:10 a.m.Assessing Stroke Risk: Who Needs to be Anticoagulated?Calvin J. Hansen\, MD\, Iowa Health Des MoinesDr. Hansen indicated he has no financial relationships to disclose relevant to the content of this CME activity.9:30 a.m.Break10 a.m. Which Drug for Which Patient? Coumadin or the Newer Agents: Current Status and ReviewSamuel J. Asirvatham\, MD10:40 a.m. Trips\, Falls\, and Spills: The Geriatrician's Perspective on AnticoagulatingDarrel E. Devick\, DO\, FACOI\, Mercy Capitol Internal Medicine ClinicDr. Devick indicated he has no financial relationships to disclose relevant to the content of this CME activity.11 a.m.Panel Discussion and Case Presentations11:30 a.m.Rate Versus Rhythm Control AFFIRMING the Right ChoiceCraig B. Clark\, DO\, FACC\, FAHA\, FASE\, Iowa Health Cardiology; Iowa Chapter of the American College of CardiologyDr. Clark indicated he has no financial relationships to disclose relevant to the content of this CME activity.12 p.m.Lunch1 p.m.Antiarrhythmic Drug Therapy in Atrial FibrillationPrasad R. Palakurthy\, MD\, FACC\, FHRS\,Electrophysiologist\, Iowa Health CardiologyDr. Palakurthy indicated he has no financial relationships to disclose relevant to the content of this CME activity.1:30 p.m.Ablative Therapy for Atrial FibrillationRobert H. Hoyt\, MD\, FACC\, FHRS\, Electrophysiologist\, Iowa Heart CenterRelevant to this CME activity\, Dr. Hoyt indicated he has received an honorarium from Medtronic and Boehringer Ingelheim.2 p.m.What the Provider Needs to Know When Their Patient Returns to the Office After an AblationChristopher J. Mcleod\, MBChB\, PhD\, Cardiology and Vascular Medicine\, Mayo Clinic\, MNDr. McLeod indicated he has no financial relationships to disclose relevant to the content of this CME activity.2:20 p.m.Recent Advances in Treatment of Atrial Fibrillation: Non-Pharmacological Stroke PreventionAlexander Mazur\, MD\, University of Iowa Carver College of MedicineDr. Mazur indicated he has no financial relationships to disclose relevant to the content of this CME activity.2:50 p.m.Break3:10 p.m.Interactive Patient Cases4:10 p.m.Provider and Patient ResourcesKevin Carnevale\, MD\, Des Moines UniversityDr. Carnevale indicated he has no financial relationships to disclose relevant to the content of this CME activity.4:30 p.m.AdjournRegistration feeAttendees will be requested to complete a short learner self-assessment survey regarding their present and desired level of ability to administer antithrombotic therapy for patients with AFib. The information will be used to enhance the learning experience. The response\, rationale\, and references to each answer will be supplied at the educational activity. We thank you in advance for your time.Physician - $50 Non-Physicians- $25Students and residents - FreeRegister onlineContactDes Moines University Continuing Medical Education3200 Grand AvenueDes Moines\, IA 50312cme@dmu.edu515-271-1596Commercial supportThis activity is funded through an educational grant from Bristol-Myers Squibb/Pfizer Pharmaceuticals Partnership to the TEAM-A Collaborative to support activities that improve the treatment of patients with Atrial Fibrillation.  The Physicians’ Institute is a member of TEAM-A and retains full control over the distribution of individual grants under this collaborative grant program. ExhibitorsThank you to St. Jude Medical\, Boehringer Ingelheim and Medtronic for their support.Continuing educationAAMA: 7.0 CEUs\, either- Clinical or General.AAFP: This Live activity\, Improving Outcomes in Patient with Atrial Fibrillation: An Update for the Primary Care Physician\, with a beginning date of 04/20/2013\, has been reviewed and is acceptable for up to 6.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.AMA PRA: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Iowa Medical Society (IMS) through joint sponsorship of Iowa Health-Des Moines (Methodist & Lutheran/Blank Children’s) and Des Moines University. Iowa Health-Des Moines (Methodist & Lutheran/Blank Children’s) is accredited by the IMS to provide continuing medical education for physicians. Iowa Health-Des Moines (Methodist & Lutheran/Blank Children’s) designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.AOA: Des Moines University is accredited by the American Osteopathic Association to present continuing medical education programs for physicians. Des Moines University and the American Osteopathic Association Council on Continuing Medical Education approve this live program for a maximum of 6.5 hours of AOA Category 1-A CME credits.IBON: Des Moines University Continuing Medical Education (provider #112) is approved by the Iowa Board of Nursing as an accredited provider. This program has been reviewed and approved for 8.0 continuing education contact hours.Other: Attendees will be given a certificate of participation for a maximum 6.75 continuing education hours.Disclosure statementThe information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Disclosure of faculty and commercial sponsor relationships (if any) will be made known at the activity.Des Moines University (DMU) prohibits discrimination in employment\, educational programs\, and activities on the basis of race\, national origin\, color\, creed\, religion\, sex\, age\, disability\, veteran status\, sexual orientation\, gender identity\, or associational preference. The University also affirms its commitment to providing equal opportunities and equal access to University facilities. Individuals with disabilities are encouraged to attend DMU sponsored activities. If you have questions/concerns\, please contact the DMU CME office at 515-271-1596 or URL: LOCATION:3300 Grand Avenue\, Des Moines\, IA\, 50312\, United States CATEGORIES:Continuing Medical Education ATTACH;FMTTYPE=: ORGANIZER;CN=Continuing Medical END:VEVENT END:VCALENDAR